Prestigious Prize Recognizes Groundbreaking Body's Defenses Research

This year's Nobel Prize in medical science was awarded for revolutionary findings that illuminate how the body's defense network targets harmful pathogens while protecting the body's own cells.

Three renowned scientists—Japan's Shimon Sakaguchi and American experts Mary Brunkow and Dr. Ramsdell—received this accolade.

The work identified unique "security guards" within the immune system that remove malfunctioning defense cells capable of attacking the body.

The discoveries are now paving the way for innovative therapies for autoimmune diseases and cancer.

The laureates will divide a prize fund worth 11 million SEK.

Crucial Findings

"Their work has been decisive for understanding how the immune system functions and the reason we don't all develop severe autoimmune diseases," commented the head of the Nobel Committee.

This team's studies explain a core question: In what way does the defense system defend us from numerous invaders while leaving our healthy cells intact?

Our body's protection system uses white blood cells that search for signs of infection, even viruses and bacteria it has never encountered.

Such defenders utilize sensors—known as receptors—that are produced by chance in countless variations.

This gives the immune system the ability to combat a wide array of threats, but the unpredictability of the mechanism unavoidably produces immune cells that may target the host.

Security Guards of the Immune System

Scientists earlier understood that some of these harmful defense cells were eliminated in the immune organ—the site where white blood cells mature.

This year's award recognizes the discovery of regulatory T-cells—known as the body's "peacekeepers"—which patrol the system to disarm other immune cells that attack the healthy cells.

We know that this mechanism malfunctions in self-attack conditions such as type-1 diabetes, multiple sclerosis, and RA.

A prize committee stated, "The findings have established a novel area of research and accelerated the creation of innovative therapies, for example for tumors and autoimmune diseases."

Regarding cancer, T-regs block the system from attacking the growth, so research are focused on lowering their quantity.

In self-attack disorders, experiments are testing boosting T-reg cells so the organism is not being harmed. A comparable approach could also be effective in reducing the chances of transplanted organ failure.

Innovative Experiments

Professor Shimon Sakaguchi, from Osaka University, conducted experiments on rodents that had their thymus removed, leading to self-attack conditions.

He demonstrated that introducing immune cells from other mice could prevent the illness—suggesting there was a system for blocking defenders from harming the body.

Dr. Brunkow, from the a research center in a US city, and Fred Ramsdell, currently at Sonoma Biotherapeutics in a California city, were investigating an inherited immune disorder in mice and people that led to the identification of a genetic factor critical for how regulatory T-cells function.

"The pioneering work has uncovered how the immune system is kept in check by regulatory T cells, preventing it from mistakenly targeting the body's own tissues," said a prominent physiology specialist.

"This research is a remarkable illustration of how fundamental physiological study can have broad consequences for public health."